Temporal studies into attachment, VE-cadherin perturbation, and paracellular migration of human umbilical mesenchymal stem cells across umbilical vein endothelial monolayers by Ebrahim, Neven A. & Leach, Lopa
ORIGINAL RESEARCH REPORTS
Temporal Studies into Attachment, VE-Cadherin
Perturbation, and Paracellular Migration of Human
Umbilical Mesenchymal Stem Cells Across
Umbilical Vein Endothelial Monolayers
Neven A. Ebrahim and Lopa Leach
Mesenchymal stem cells from Wharton’s jelly of human umbilical cords (WJ-MSC) are a valuable alternate
source of stem cells. Their role in situ and whether they can interact and cross intact endothelial monolayers
requires elucidation. The aim of this study was to investigate the dynamic interactions between WJ-MSC and
human umbilical vein endothelial cells (HUVEC), including attachment, transit times, extravasation pathway, and
the effects of WJ-MSC on junctional vascular endothelial (VE)-cadherin. HUVEC were grown to near confluence
in endothelial media and to full confluence in mixed media before the addition of PKH26-labelled WJ-MSC.
Time lapse fluorescence microscopy showed stem cells undergoing membrane blebbing followed by amoeboid
movement on HUVEC monolayers before rounding up and changing shape toward the spindle-shaped mor-
phology during/after transmigration to subendothelial positions. Cells demonstrated a time lag of 60 min before
paracellular extravasation, confirmed by confocal microscopy. Forty-six percent of attached cells crossed in the
first 2 h. By 16 h, a majority of cells had transmigrated with > 96% of cells crossing by 22 h. There were
concomitant changes in endothelial junctional VE-cadherin with statistically significant increases in discontinuous
staining at 2 h, return to control values at 16 h, even as from 22 h onward HUVEC displayed increased percentage
of junctions with continuous staining and upregulation of protein. Our data suggests that WJ-MSC crosses the
endothelial barrier through the paracellular pathway and can influence junctional organization of HUVEC with
discreet perturbation of VE-cadherin preceding transmigration followed by upregulation once the adluminal side
is reached. The latter may reflect a perivascular support function of WJ-MSC in the umbilical cord.
Introduction
The Wharton’s jelly (WJ) of the umbilical cord isderived from the mesoderm of the primitive streak,
which invades the connecting stalk and primary chorionic
villi early in gestation. Mesenchymal stem cells (MSC) of
the mesoderm differentiate into and participate in neo-
vasculogenesis of both the umbilical and placental circula-
tion. The WJ at term continues to encase the fetal umbilical
vein and arteries (two) and still contain multipotent MSCs
[1]. The role of these cells throughout gestation is not known,
although paracrine cross-talk may be important for vessel
growth, maturation, and function. MSCs from the umbilical
cord can be easily isolated after parturition. Their phenotype
is similar to adult bone marrow stem cells, but being fetal
they have the added advantage of advanced potency and less
immunogenicity than adult stem cells [2]. This makes them
an attractive source for future stem cell therapy, although
their fundamental biology still remains underresearched.
Currently, a large number of clinical trials are underway
evaluating adult bone marrow-derived MSCs (BM-MSCs)
for the treatment of cardiovascular, inflammatory, and au-
toimmune diseases. Most involve systemic infusion of MSC
into the vascular circulation [3] and thus cells have to ex-
travasate to target areas. In vitro studies have shown that
MSC transmigrate, similar to leukocytes, through predomi-
nantly paracellular and also transcellular pathways in acti-
vated endothelium [4]. The authors reported that the
initiation of transmigration occurred by 30 min with 50% of
stem cells completing transmigration after 120 min. Using
an isolated murine heart perfusion system, Schmidt et al. [5]
have shown that MSC transmigrate through the paracellular
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junctions, with one third of the cells migrating within
30 min, suggestive of a faster transit time in vivo. Whether
WJ-MSC uses the paracellular route and the duration of
attachment and transmigration events is not known and is
the central aim of this study.
In most non-CNS vascular beds, paracellular permeability
is regulated in a dynamic manner by adherens junctions
(AJs), with vascular endothelial (VE)-cadherin being the
key player [6]. Phosphorylation of VE-cadherin and loss of
anchorage leads to translocation of this molecule from ad-
herens junctional domains and accompanying increased
paracellular permeability to hydrophilic solutes and ex-
travasating blood cells [5]. In the endothelium with tighter
barriers, such as the blood–brain barrier, tight junctions also
regulate the paracellular passage of cells, molecules, and
ions. Human umbilical vein endothelial cells (HUVEC) are
a useful and favored in vitro model for endothelial barrier
studies and are easily isolated from the umbilical cord. The
close proximity between the WJ-MSC and the umbilical
vein endothelial cells in situ and their developmental origins
makes the use of HUVEC doubly pertinent for this study.
Using real-time fluorescence microscopy and confocal
scanning microscopy, the cellular mechanisms used in the
attachment and transmigration of WJ-MSC across HUVEC
monolayers, the time taken, and the associated dynamics of
the junctional VE-cadherin was, therefore, investigated. Data
obtained may also reveal the importance of paracrine cross talk
between umbilical stem cells and blood vessels for the con-
tinued maintenance of endothelial integrity during gestation.
Materials and Methods
Isolation and culture of cells
Term umbilical cords (n = 20) were obtained at elective
Cesarean section from normal pregnancies with informed
patient consent, full ethical approval (REC Ref 14/SC/
1194, NHS Heath Research Authority), and NHS permis-
sion from Nottingham University Hospitals, NHS Trust,
UK. WJ-MSC were non-enzymatically isolated using the
method of De Bruyn et al. [7]. WJ-MSC migrating from
umbilical cord segments on plastic Petri dishes were cul-
tured in a stem cell growth medium [DMEM/Low Glucose
(Hyclone) with 15% fetal bovine serum (FBS; Sigma) and
antibiotic/antimycotic solution (Hyclone)]. They were
characterized according to the Mesenchymal and Tissue
Stem Cell Committee of the International Society for Cel-
lular Therapy [8] by flow cytometry FC 500 (Beckman
Coulter) with 50,000 events captured. Results were ana-
lyzed using the WEASEL v3.0 for Windows (Walter and
Eliza Hall Institute). The ability to differentiate into adi-
pocytes, chondrocytes (according to Pittenger et al. [9]),
and osteocytes (according to Santos et al. [10]) was verified.
Endothelial cells (HUVEC) were isolated from freshly
collected term umbilical cords using the method of Ha-
milton and Leach [11]. They were grown up to passage 3 on
gelatin-coated flasks and were maintained in endothelial
medium [Medium 199 (Gibco) with 20% FBS + heparin
sodium salt (50 mg/mL), endothelial cell growth supplement
(50 mg/mL)]. The endothelial specific cell–cell adhesion
molecule, VE-cadherin (Pharmingen, BD Biosciences) and
von Willebrand Factor (vWF; Dako) was used to check the
junctional maturity and homogeneity of HUVEC.
Effect of mixed media on the cells
Before the coculture study, the ability of HUVEC to attach
and grow to confluence in mixed endothelial and stem cell
growth media (50% endothelial medium + 50% stem cell
medium) was ascertained by microscopical observations.
Changes, if any, of the endothelial markers VE-cadherin and
vWF in HUVEC was investigated by immunocytochemistry
(see Immunohistochemistry section below). WJ-MSC at
passage 3, 4, and 5 were labeled with PKH26 fluorescent dye
(Sigma-Aldrich) according to the manufacturer’s instruc-
tions. Similarly, the ability of labeled WJ-MSC to attach,
grow, and proliferate on 1% gelatin in mixed media was also
investigated. WJ-MSC were cultured at an initial cell density
of 64 cells/mm2 for 22 h. The attached cells were photo-
graphed and 10 unbiased images were taken for the 2, 16, and
22 h groups (three experimental repeats) using phase con-
trast microscopy. Every second image was selected from
each group and the number of cells counted. The mean
number of cells/mm2 was calculated. The labeled WJ-MSC
were also subjected to immunocytochemistry to localize any
VE-cadherin expression in mixed media.
Coculture studies
To obtain cocultures of HUVEC in contact with WJ-
MSC, 100,000 HUVEC were seeded on a 1% gelatin-coated
coverslip (19 mm diameter) and incubated in endothelial
media (three different isolates were tested, with three ex-
perimental repeats). Once 70% confluence was reached, the
media was changed to mixed media. On full confluence (18–
24 h later) 20,000 labeled WJ-MSC were seeded on top of
the confluent HUVEC monolayer (1:5 ratio) per coverslip in
1 mL of the mixed media [12]. HUVEC monolayers without
added WJ-MSC in mixed media were used as a control. WJ–
MSC–HUVEC interaction was observed at different time
intervals (2, 4, 6, 22, and 26 h) by an inverted phase mi-
croscope and photographed.
Real time observations
Cocultures of WJ-MSC on HUVEC on glass-bottomed
tissue culture dishes (Ibidi GmBH) were observed with
DMIRE2 time-lapse fluorescent microscope with a built-in
environmental chamber and a color CCD camera (Leica
DC300FX) and also with a wide-field fluorescence micro-
scope (Deltavision Elite; Applied Precision). Cells were
observed for 40 h. All data analyses were carried out using
the Volocity software (Perkin Elmer).
Immunohistochemistry of VE-cadherin
and systematic random sampling
To localize VE-cadherin in HUVEC and monitor the effects
of labeled WJ-MSC on VE-cadherin, cocultured cells were
fixed with 1% paraformaldehyde, pH 7.3 at different time in-
tervals (2, 4, 6, 12, 14, 16, 22, and 26 h). They were permea-
bilized for 10 min with 0.15% Triton X-100, blocked in 5%
goat’s serum in phosphate buffered saline (PBS) for 30 min and
incubated overnight at 4C with mouse anti-Human CD144
(VE-cadherin; 5mg/mL). Cells were washed with 0.1% PBS/
BSA and incubated with FITC-conjugated goat anti-mouse IgG
(Sigma) for 2 h in the dark at room temperature (RT). The
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coverslips were mounted using Vectorshield. They were ana-
lyzed using a Nikon fluorescence microscope with appropriate
filters to allow visualization of both FITC and PKH26. Loca-
lization and continuous/discontinuous staining pattern of en-
dothelial cell–cell junctions and position of labeled WJ-MSC
was photographed with the CCD camera (Nikon DS) for the
chosen intervals of coculture and stored (NIS elements F3.0;
Nikon). HUVEC alone and labeled WJ-MSC alone for similar
durations of culture in mixed media were also subjected to VE-
cadherin immunocytochemistry to obtain appropriate controls.
Junctional counts
Stored Images (duration of coculture was blinded) were used
to count the percentage of paracellular clefts showing continu-
ous or discontinuous (disrupted) VE-cadherin staining in con-
trol and treated HUVEC monolayers. To ensure that all cell–cell
junctional regions had an equal chance of being counted, a grid
was placed on images and paracellular clefts from every other
square were counted and categorized according to staining
pattern. The position and number of the labeled WJ-MSC,
apical, or sub-endothelial and their proximity to discontinuous
junctions were recorded for the cocultures.
Statistical analysis
Data were analyzed using the two-way ANOVA (Prism 6
software) and Bonferroni’s multiple comparison test to
compare control versus stem cell treated group at 2, 16, and
22 h. Tukey’s multiple comparison test was used to compare
controls alone and cocultures alone at the same time inter-
vals. Statistical significance was taken at P< 0.05.
Confocal imaging
Immunocytochemically labeled cocultures at 2 and 22 h
were further analyzed with confocal scanning microscopy
(Zeiss Axiovision; Zeiss) and the Zen 2009 software for
multichannel acquisition and image processing. The pinhole
diameter used in all confocal imaging was 1 airy unit. Op-
tical slices (0.5–0.6 mm intervals) were taken and Z-tilts
were obtained to visualize transmigration pathways.
Western blotting
Confluent HUVEC monolayers were cocultured with or
without WJ-MSC (1:5 ratio). The early hours of interaction
(0, 2 h) and late (22 h) were chosen to measure VE-cadherin
protein levels. WJ-MSC alone was grown in mixed media
on gelatin and cells at 0, 2, and 22 h were used for immu-
noblotting. Briefly, cells were scraped and lysed in a 200mL
Lysis buffer [20 mM Tris (Invitrogen) + 320 mM sucrose
(BDH) + 0.1% Triton X-100 + 1 mM NaF + 10 mM b gly-
cerophoshate+ 1 mM EGTA and protease inhibitor; pH 7.6].
Denatured proteins were separated in a 4%–20% gradi-
ent polyacrylamide gel after equal loading (15mL) and
FIG. 1. Flow cytometric analysis of WJ-MSC (P3) for hematopoietic (A–E) and MSC surface markers (F–J). (A–E) The
dark gray histograms (M) represent cells labeled with hematopoietic markers; light gray (C) are control; percentages
indicate the labeled marker rates. Less than 2% of WJ-MSC are immunopositive to the hematopoietic markers CD14, CD19,
CD45CD, HLA-DR, and CD 34. (F–J) The dark gray (M1) represents CD29 and the black (M2) represents CD90, CD105,
CD73, and CD44 respectively; light gray histograms (C) are negative control. Greater than 96% show immunopositivity to
the mesenchymal markers CD 29, CD90, CD105, and CD73 and 74.9% were positive to CD44. WJ-MSC from all passages
used (before and after freezing) showed similar profiles. WJ-MSC, mesenchymal stem cells from Wharton’s jelly of human
umbilical cords.
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FIG. 2. (A–C) Immunofluorescence analyses of HUVEC grown in endothelial medium (A, B) versus mixed media (C).
VE-cadherin is localized to cell–cell boundaries and display a predominantly continuous staining whereas punctate vWF
staining is found in the cytoplasm. A similar continuous pattern of VE-cadherin can be seen in mixed media; Bar = 40mm.
(D–I) Images of PKH26-labeled WJ-MSC in mixed media on 1% gelatin-coated coverslips at 2, 16, and 22 h. Phase contrast
images (D–F) show attachment, change in morphology toward the elongated spindle-shape and increasing confluence with
time, Bar = 200mm. Fluorescence micrographs (G–I) of labeled WJ-MSC (red) immunostained for VE-cadherin (green).
Cells are immunonegative at each duration; Bar = 40mm. HUVEC, human umbilical vein endothelial cells; VE, vascular
endothelial; vWF, von Willebrand Factor. Color images available online at www.liebertpub.com/scd
FIG. 3. (A, B) Micrographs
from time lapse photography
(0–2 h) showing blebbing
phenomenon of all PKH26-
labeled WJ-MSC when added
to HUVEC monolayer. Bar=
6mm. (B) A higher magnifi-
cation of A (· 2.5) of one
cell (circle and arrow). (C)
Micrograph from time-lapse
photography showing shedding
of PKH26-labeled exosomes
from WJ-MSC overlying
HUVEC; Bar=22mm. Color
images available online at
www.liebertpub.com/scd
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transferred to a nitrocellulose membrane. After blocking
with 5% skimmed milk powder in 0.1% Tris buffered saline
with Tween 20 for 60 min at RT, the membranes were in-
cubated with the antibodies against VE-cadherin (1:1,000
dilution; Cell Signalling) and GAPDH (1:3,000; Sigma). A
Li-cor Odyssey scanner and Odyssey software (Image Stu-
dio Version 3.1.4) were used to measure optical densities.
The VE-cadherin protein expression (normalized using
GAPDH as loading control) for the different durations and
study groups (three experimental repeats) were obtained. Data
FIG. 4. (A–F) Micrographs from time-lapse photography (every 15 min for 1.5 h) showing behavior of labeled WJ-MSC
over HUVEC monolayers. Cell 1 can be seen displaying blebbing behavior (A, B) followed by rounding (after 30 min; C),
and flattening (D–F). Cell 2 can be seen blebbing (A, B), crawling (C), rounding (D), and flattening (E, F). (G–L)
Micrographs from a second time-lapse movie (every 15 min for 1.5 h). Cell 3 can be seen demonstrating pseudopodia and
crawling movement over HUVEC monolayer (G–I), rounding (J, K) before becoming spindle shaped (L). From (A–C)
micrographs were focused on WJ-MSC, whereas micrographs from (D–L) were focused on HUVEC. WJ-MSC have not
crossed the HUVEC monolayer in these micrographs of early events. Secreted PKH26-labeled exosome (yellow arrow) can
be seen in ( J), (K), and (L). Bar = 6 mm. Color images available online at www.liebertpub.com/scd
430 EBRAHIM AND LEACH
were analyzed using two-way ANOVA and Sidak’s multiple
comparison test. Statistical significance was taken at P< 0.05.
Results
Characterization of isolated WJ-MSC and HUVEC
Under our laboratory conditions, WJ-MSC took 25– 5
days to migrate from cord segments, adhere, and reach con-
fluence. In subsequent passages (up to P4) the confluence
time was halved in each passage and the confluent cell counts
reached to 5 · 106 cells/mL. Flow cytometric analysis of WJ-
MSC from passage 3, 4, and 5 (before and after freezing)
revealed ( > 95%) from each passage, and were positive for
the mesenchymal markers CD29, CD105, CD90, CD73,
whereas 74.9% were positive for CD44. Less than 2% of the
cells showed positivity to the hematopoietic markers CD34,
CDHLA-DR, CD14, CD19, and CD45 (Fig. 1). In addition,
the cells were able to differentiate into trilineage mesen-
chymal cells such as adipocytes, chondrocytes, and osteo-
cytes when induced (data not shown).
Confluent HUVEC (P2, P3) monolayers expressed VE-
cadherin at cell–cell contacts. The pattern of staining was
predominantly continuous ( > 90% of cell–cell borders;
Fig. 2A).
Effect of mixed media on WJ-MSC and HUVEC
PKH26-labeled WJ-MSC displayed no alteration in mor-
phology and retained the dye over an observed 10 days. They
attached to 1% gelatin-coated coverslips and grew to 70%
confluence by 22 h in mixed stem cell/endothelial media. The
cells displayed proliferation: at 2 h, counts revealed a mean cell
density of 82 cells/mm2, which increased to 320 cells/mm2 at
16 h, whereas at 22 h there were on average 487 cells per mm2
(Fig. 2D–F). The cells displayed the transition of cell shape—
from rounded to intermediate to elongated spindle shaped with
time over the observation period (Fig. 2D–I). They displayed
negative immunoreactivity to anti-VE-cadherin antibodies
(Fig. 2G–I). HUVEC also continued to show the typical cob-
blestone appearance and positivity to the endothelial marker
before and after addition of the mixed media for the durations
tested (Fig. 2A–C). Continuous VE-cadherin staining was seen
in 88+ 1.6 SD% of cell–cell junctions when cells reached full
confluence in mixed media.
Coculture studies
Early coculture interactions. With phase contrast micros-
copy, WJ-MSC were seen to attach to the HUVEC mono-
layer within 30 min and appeared to display morphological
changes—from rounded to transitional to spindle shaped. The
position of these cells in relation to the endothelial layer was
difficult to decipher at the magnifications allowed. Real-time
imaging (every 15 min) with a time lapse fluorescence micro-
scope showed that soon after addition of PKH26-labeled WJ-
MSC on HUVEC monolayers they displayed membrane
blebbing (Fig. 3A, B) and shedding of PKH26-filled exosomes
(Fig. 3C). The blebbing behavior was followed by pseudopo-
dial extensions and amoeboid movement (Fig. 4) over HU-
VEC. Cells were then observed to round up and change shape
toward the spindle-shaped morphology (Fig. 4). PKH26-filled
exosomes were shed throughout this period.
Transmigration events. Fluorescent micrographs of im-
munostained cocultures from different durations showed
that transmigration of cells from the apical surface to sub-
endothelial layers started from 60 min onwards. At 2 h,
46%– 11% of all attached WJ-MSC were found in sub-
endothelial locations. At 16 h, the majority of WJ-MSC
(95%– 4%) was found in sub-endothelial position. 96%– 3%
of WJ-MSC were found in sub-endothelial positions at 22 h.
VE-cadherin dynamics. The pattern of VE-cadherin lo-
calization was observed to differ in HUVEC monolayers
with or without added PKH26-labeled WJ-MSC at 2, 16,
and 22 h. Control HUVEC monolayers (no added stem cells)
showed the presence of VE-cadherin at cell–cell boundaries,
with a predominant continuous staining pattern at all time
points (Fig. 5). In cocultures, attachment and paracellular
FIG. 5. (A–L) Micrographs showing localization of VE-cadherin (green) in HUVEC monolayers without (A, D, G) or
with added PKH26-labeled WJ-MSC (red) at 2, 16, and 22 h (B, C, E, F, H–L). (A, D, G) Control HUVEC monolayers
show presence of VE-cadherin at cell–cell boundaries, with a predominant continuous staining pattern at all time points. (B)
Image of coculture with FITC filter only showing VE-cadherin localization in HUVEC after 2 h of coculture with WJ-MSC.
Cell–cell junctions with discontinuous VE-cadherin pattern or loss of staining (arrow) can be seen. (C) Superimposed
images (FITC/TRITC filters) of the same area showing position of WJ-MSC (red) to the discontinuous cell–cell junctions.
They can be seen overlying or in close association with the disrupted cell–cell borders. (E, F) Similar dual images at 16 h of
coculture show colocalization of WJ-MSC at disrupted cell–cell junctions. (H, I) At 22 h of coculture, increased numbers of
cell–cell borders contain a continuous VE-cadherin staining. In the merged image (I) WJ-MSC can be seen underlying the
HUVEC monolayer. Bar = 40 mm for images (A–I). ( J–L) Merged images at higher magnification at 22 h coculture from
different experimental repeats, Bar = 20 mm. Full junctional occupancy of VE-cadherin can be seen in cell–cell boundaries
overlying WJ-MSC (J). Sub-endothelial position of WJ-MSC can be seen in (K) and (L). Again overlying junctions show
full VE-cadherin occupancy. Note discreet shed exosomes can be seen in coculture images. (M) Histogram of percentage of
continuous VE-cadherin junctions at different time points for control and cocultured cells. Two-way ANOVA revealed a
significant decrease at 2 h (P < 0.0001) and significant increase at 22 h (P< 0.001) in the cocultures compared with control.
Junctional continuity was also statistically significant at each duration of coculture (P < 0.0001) (N). Representative western
blot showing expression of VE-cadherin. PKH26-labeled WJ-MSC show negative expression (S0h, S2h, S22h) for each
duration, HUVEC without WJ-MSC (E0h, E2h, E22h) show no change in expression with duration of culture whereas an
upregulation of VE-cadherin can be seen in at 22 h in HUVEC cocultured with WJ-MSC (C0h, C2h, C22h). GAPDH acted
as loading control. (O) Histogram showing mean optical density + SEM of normalized VE-cadherin expression from three
different blots of control HUVEC and cocultures at 2 and 22 h. No significant changes were seen in the control groups.
There was a significant upregulation of VE-cadherin expression at 22 h in the coculture group (P < 0.01). Color images
available online at www.liebertpub.com/scd
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transmigration across the endothelial layer was observed
from 2 h and was concomitant with changes in VE-cadherin
staining pattern to a discontinuous, stitch-like, or no staining
pattern in *35% of all cell–cell junctions. Specifically,
HUVEC with overlying or transmigrating labeled WJ-MSC
showed junctional disruption (Fig. 5B, C) compared with
continuous VE-cadherin staining seen in HUVEC distant
from WJ-MSC. A similar pattern of disruption related to
stem cell proximity was seen in 16 h cocultures. The stem
cells overlying HUVEC, traversing intercellular gaps and in
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sub-endothelial positions were all immunonegative to VE-
cadherin. At 22 h all WJ-MSC were observed in sub-endothelial
position with overlying paracellular clefts showing full oc-
cupancy of VE-cadherin (Fig. 5J–L).
Quantitative analyses (Fig. 5M) revealed a statistically
significant decrease (64.9%; P < 0.0001) in the percentage of
cell–cell borders showing continuous VE-cadherin staining
at 2 h compared to control HUVEC (80.9%– 2.9%). At 16 h
both control and treated groups had similar (76.9%– 4.6%
vs. 79.2% – 3%) continuous junctional profiles. At 22 h, the
percentage of continuous junctions were statistically higher
(93.4 – 3.2) in the WJ-MSC-treated samples versus the
control (78.8%– 3.4%; P < 0.001). Intraspecific compari-
sons of groups showed that junctional staining pattern in
control HUVEC monolayers were not significantly different
at 2, 16, and 22 h whereas in treated groups the percentage
of continuous junctions differed at each time point of co-
culture (P < 0.001).
Western blot analyses (n= 3) of cocultures and control
monolayers at 2 and 22 h showed that that WJ-MSC did not
express VE-cadherin, whereas HUVEC showed differential
expression dependent on treatment and duration of stem cell
interaction (Fig. 5N). Statistical analysis revealed no sig-
nificant change in VE-cadherin values (normalized against
GAPDH) in the control groups from 2 to 22 h, whereas the
cocultures showed significant upregulation of VE-cadherin
protein in the same time interval (P £ 0.01; Fig. 5O). This
intraspecific difference corresponded with junctional chan-
ges seen by immunofluorescence analyses.
Confocal microscopy of cocultures, immunostained with
VE-cadherin and tilting at the Z axis confirmed attachment
and paracellular transmigration of WJ-MSC across the en-
dothelial layer at 2 h, (Fig. 6A–D). Furthermore, Z-tilts
confirmed basal position of all stem cells at 22 h (Fig. 6E–
G). The endothelial cell–cell junctions showed the contin-
uous VE-cadherin pattern above the transmigrated stem
cells.
Discussion
This study showed that human MSCs isolated from the
umbilical cord can cross the endothelial barrier without
causing endothelial damage. The transmigration appeared to
be similar to that shown for bone marrow stem cell migra-
tion [4], taking a period of hours rather than minutes. WJ-
MSC demonstrated nonapoptotic blebbing upon addition,
amoeboid motility, changes in cell shape, and paracellular
transmigration to the sub-endothelial layer. Our data also
suggests that WJ-MSC can influence junctional expression
of the paracellular adhesion molecule VE-cadherin, with
VE-cadherin perturbation as an early event followed by
transmigration and a full return of VE-cadherin to junctional
domains. Indeed, once WJ-MSC were in the sub-endothelial
niche, they appeared to upregulate both VE-cadherin protein
expression and their occupancy at HUVEC–cell borders.
Exposure of PH26-labeled WJ-MSC to 50% endothelial
media did not alter their ability to attach, proliferate, grow
to confluence, and retain the dye (Fig. 2). They did not
demonstrate phenotypic alteration toward the endothelial
lineage—they continued to be negative for VE-cadherin
when grown in mixed media or when cocultured with
HUVEC. Addition of 50% stem cell media to HUVEC at
near confluence did not alter its ability to reach full con-
fluence within 24 h. Junctional maturity (as evidenced by
continuous VE-cadherin staining) and vWF expression was
similar to that seen in HUVEC grown in 100% endothelial
medium. There were no statistically significant differences
in the percentage of junctions showing continuous VE-
cadherin at 2, 16, or 22 h in mixed media alone (control; Fig.
5). In cocultures there was a significant upregulation of total
protein in HUVEC after 96% of WJ-MSC had transmigrated
to the adluminal (sub-endothelial) position. This increase
was due to the changes in HUVEC since WJ-MSC remains
immunonegative for VE-cadherin at all durations of cocul-
ture (Fig. 5N). However, where VE-cadherin resides, junc-
tional occupancy rather than cytoplasmic location, dictates
barrier integrity [6]. Thus the observed changes in junctional
VE-cadherin staining with duration of coculture were re-
vealing (Fig. 5). The statistically significant increase in
disruption of the VE-cadherin AJs in the HUVEC mono-
layer was an early event and peaked at 2 h after introduc-
tion of WJ-MSC (Fig. 5). Transendothelial migration of
WJ-MSC started from 60 min and *46% of cells had
transmigrated by 2 h. Return of VE-cadherin and full junc-
tional occupancy was a postmigratory event, starting around
16 h and reaching a higher percentage continuous than
control HUVEC monolayers at 22 h. VE-cadherin protein
expression was at its highest at this point.
The discreet but significant perturbations of HUVEC–cell
borders, which started from 60 min are reminiscent of that
seen for vasoactive agents such as VEGF and histamine
[13,14]. These inflammatory mediators have a biphasic re-
sponse with rapid transendothelial pore formation (minutes)
followed by a paracellular distension after 30–60 min [15–
17]. The delayed interaction we observed argues toward VE-
cadherin relocation to facilitate transmigration. BM-MSC
have been shown to migrate through the paracellular path-
way of human brain micro-VE cell monolayers, through the
disruption of ZO-1 and occludin and alteration of tight
junction integrity [18]. The postmigratory return of VE-
cadherin in our cocultures agrees with other studies. Pati et
al. showed that BM-MSC can reduce HUVEC monolayers
permeability in vitro after 24 h with enhanced VE-cadherin/
b-catenin interactions [12]. Menge et al. showed that BM-
MSC inhibit HUVEC proliferation and angiogenesis after 2
days of coculture through the modulation of VE-cadherin/b-
catenin signaling pathway [19]. Our studies show that um-
bilical mesenchymal cells have a similar ability; moreover
we show that this is preceded by paracellular VE-cadherin
disruption during transmigration. The return of VE-cadherin
and HUVEC confluence seems to be related to a paracrine
conversation between WJ-MSC and HUVEC. According to
[20] WJ-MSC can stimulate neovascularization by secreting
paracrine factors and by acting as perivascular precursor
cells. The observed shedding of exosomes before trans-
migration suggests that exosomal signaling may also be
an early event (Figs. 3 and 4). Released exosomes from
placental mesenchymal cells have been shown to have a
dose-dependent effect on migration and tube formation of
placental micro-VE cells [21]. Whether exosomal signaling
can induce junctional disruption requires investigation and
is underway in our laboratory.
Our real-time studies (Figs. 3 and 4) revealed that trans-
migration is not an all or nothing event, with all added cells
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transmigrating soon after addition. Increasing number of
WJ-MSC crossed the endothelial barriers over the 24 h ob-
servation period, with migration starting around 60 min.
Forty-six percent of attached cells crossed in the first 2 h and
the remainder continued crossing up to the 24 h. The initial
lag phase and prolonged duration is similar to an in vivo
study of the perfused mouse heart, where Schmidt et al.
reported that 50% of introduced bone marrow stem cells
migrated through the endothelial barrier within 60 min
perfusion [5]. We did not see any reverse trafficking of
migrated cells. Once the sub-endothelial position was
reached, cells attached and became quiescent. This may be
the consequence of improved adhesion of WJ-MSC on
gelatin. In our study we used isolated MSCs from the in-
cised umbilical cord. These cells showed essential MSC
characteristics such as plastic adherence, tripotency, and
expression of CD29, CD105, CD90, CD73, and CD44.
However, heterogeneous populations of MSCs, both in or-
igin (pericytic or fibroblastic) and differentiation potency is
now a hotly discussed topic [22] and may explain the re-
ported vascular repair potential of MSCs. Of the 20,000 WJ-
MSC added to each endothelial-lined well and grown in
mixed media, only a proportion (*50%) of the added stem
cells crossed the endothelial barrier. The ability of this co-
hort to survive (adapt) in 50% endothelial media and their
preference for the sub-endothelial niche is suggestive of the
existence of cells with different lineage potential in the
> 96% pure characterized MSCs. Thus these stem cells may
be more amenable to perivascular lineage commitment. In-
deed the subsequent maturation of endothelial VE-cadherin
FIG. 6. (A–G) Confocal composite mi-
crographs of optical sections. (A–D; 22 sli-
ces at 0.5 mm intervals and E–G; 10 slices at
0.6 mm intervals) of PKH26 (red)-labeled
WJ-MSC cocultured with VE-cadherin
(green)-labeled HUVEC, where VE-cadher-
in clearly demarcates cell–cell contact re-
gions of the monolayer. Images were tilted
on the Z-axis at varying angles with the
Volocity Software, starting from the sub-
endothelial position. (A, B) At 2 h coculture,
three WJ-MSC (1, 2, 3) can be seen tra-
versing at cell–cell borders, where VE-cad-
herin staining is disrupted or absent. Cell 4 is
seen fully attached and spread under the
HUVEC monolayer. (C, D) confirms the
paracellular transmigrating of cells 1–3.
Bar = 120 mm. (E–G) Confocal micrographs
of optical sections of cocultures at 22 h, til-
ted with Volocity software, starting from a
sub-endothelial position; Bar = 100mm. (E,
F) Elongated spindle-shaped WJ-MSC (5)
can be seen under the HUVEC monolayer
traversing over several cells. Tilting to the
apical surface of the monolayer (G) dem-
onstrates repair of the junctional regions
with full occupancy of VE-cadherin (con-
tinuous staining) in paracellular clefts over-
lying the stem cell (5). Color images
available online at www.liebertpub.com/scd
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junctions seen in HUVEC at 22 h coculture mimics an en-
dothelial-pericyte cross-talk and gives credence to this hy-
pothesis.
The blebbing behavior of the WJ-MSC upon introduction
was observed not to be an apoptotic phenomenon. The very
same cells were then seen to display amoeboid movement
and change shape (Fig. 4). This type of membrane changes
after trypsinization of adhered cells and addition to new
extracellular matrix has been shown for cells; indeed bled-
mediated migration for navigation and mechanical homeo-
stasis is a critical cellular activity [23]. Teo et al. [4] also
attributed blebbing of bone marrow stem cells to low
avidity interaction between endothelium and MSC, whereas
quenching of blebbing may be promoted by contact with the
sub-endothelial matrix after transmigration. WJ-MSC in our
study showed exactly the same response in their search for
new optimal attachment sites at the sub-endothelial niches
(Figs. 3 and 4). As stated before, in our study, confocal
microscopy and Z-tilting indicate that emigration sites for
WJ-MSC were at cell–cell contact regions (Fig. 6). Trans-
cellular migration was not observed, but cannot be excluded.
The time taken to transmigrate was similar to that seen for
bone marrow stem cells rather than leucocytes [24].
In conclusion, this study is the first to show the early
events of transmigration of WJ-MSC isolated from the hu-
man umbilical cord through HUVEC. Our data adds strength
to the observations that alteration in VE-cadherin localiza-
tion at junctional domains accompanies MSC migration to
perivascular regions. The traffic to sub-endothelial regions
and influence on endothelial integrity and VE-cadherin
occupancy suggest that WJ-MSC have an important peri-
vascular/pericytic function, in general, and throughout ges-
tation, in particular.
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